BODY & MIND INC.
Healthcare · Pharmaceutical Preparations · NV · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | |
|---|---|---|---|---|---|---|
| Revenue | $22.8M | $23.4M | $26.9M | $6.2M | $5.3M | $2.7M |
| Operating income | −$7.7M | −$4.5M | $587,327 | −$5.5M | −$2.8M | — |
| Net income | −$20.6M | −$28.2M | −$2.0M | −$4.6M | −$3.8M | −$1.8M |
| Total assets | $21.2M | $31.0M | $48.1M | $38.8M | $36.2M | $15.5M |
| Total liabilities | $30.5M | $20.9M | $13.8M | $5.5M | $3.0M | $4.7M |
| Equity | −$10.3M | $9.6M | $34.3M | $33.3M | $33.2M | $10.8M |
| EPS (diluted) | — | — | — | — | — | — |
| Shares out. | 146.6M | 113.7M | 110.6M | 108.4M | 101.8M | 64.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2023- Operating margin
- −33.6%
- Net margin
- −90.1%
- Return on equity
- 200.2%
- Return on assets
- −97.0%
- Return on capital (ROCE)
- −56.7%
- Liabilities / assets
- 144.0%
- Debt / equity
- —
- Book value / share
- $-0.07
- Revenue growth (YoY)
- −2.4%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2023- Altman Z″ (distress)
- -12.56distress
- Accruals / assets
- −78.9%clean
- Beneish M-Score
- -6.01normal
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 5 warning● 2 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Oct 29, 2024
- NT 10-Qmissed a reporting deadline ↗Jun 14, 2024
- NT 10-Qmissed a reporting deadline ↗Mar 18, 2024
- NT 10-Qmissed a reporting deadline ↗Dec 15, 2023
- NT 10-Kmissed a reporting deadline ↗Oct 30, 2023
- NT 10-Qmissed a reporting deadline ↗Jun 14, 2023
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Completed an acquisition or disposition · Other material eventSep 5, 2025
- Entered a material agreement · Other material eventAug 13, 2025
- Entered a material agreement · Completed an acquisition or disposition · New financial obligationJun 12, 2025
- Entered a material agreement · Other material eventApr 23, 2025
- Entered a material agreement · New financial obligation · Other material eventApr 9, 2025
- Prior financials not reliable (restatement) · Other material eventFeb 6, 2025
- Entered a material agreementFeb 3, 2025
- Regulation FD disclosureJan 30, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-KFORM 8-KSep 5, 2025
- 8-KFORM 8-KAug 13, 2025
- 8-KFORM 8-KJun 12, 2025
- 8-KFORM 8-KApr 23, 2025
- 8-KFORM 8-KApr 9, 2025
- 8-KFORM 8-KFeb 6, 2025
- 8-KFORM 8-KFeb 3, 2025
- 8-KFORM 8-KJan 30, 2025
- 8-KFORM 8-KJan 29, 2025
- 8-KFORM 8-KJan 21, 2025
- 8-KFORM 8-KJan 10, 2025
- 8-KFORM 8-KJan 6, 2025
- 8-KFORM 8-KDec 30, 2024
- 8-KFORM 8-KDec 13, 2024
- 8-KFORM 8-KDec 2, 2024
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.